|0.13|| 0.00 / 0.00%|
GenSpera, Inc. is a development-stage pharmaceutical company, which focuses on the discovery and development of prodrug cancer therapeutics for the treatment of cancerous tumors, including prostate, brain and other cancers. Its technology platform combines, plant-derived cytotoxin (thapsigargin) with a prodrug delivery system that targets the release of the drug only within the tumor. The company was founded by Craig A. Dionne John T. Issacs and Samuel R. Denmeade on November 21, 2003 and is headquartered in San Antonio, TX.
|Russell B. Richerson||CEO, COO, Secretary & Principal Accounting Officer|